Wen-KaiWengMD

Oncology • Stanford, CA

Hematologic Oncology

Associate Professor, Medicine - Blood & Marrow Transplantation, Stanford University Medical Center

Join to view full profile

Dr. Weng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Weng's full profile

Already have an account?

Office
300 Pasteur Dr
Bmt, Room H3249, Mc5623
Stanford, CA 94305
Phone+1 650-723-7689
Is this information wrong?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1999 - 2004
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1996 - 1999
Chung Shan Medical UniversityClass of 1988

Certifications & Licensure

CA State Medical License 1999 - 2024
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma Start of enrollment: 2000 Aug 01
Completed
Phase 2
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma Start of enrollment: 2000 Apr 01
Completed
Phase 2
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment Start of enrollment: 2000 Nov 01
Completed
Not Applicable
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma Start of enrollment: 2009 May 01
Completed
Phase 2
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG Start of enrollment: 2009 May 01
Completed
Phase 2
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Start of enrollment: 2011 Mar 01
Completed
Phase 2
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level Start of enrollment: 2011 May 01
Completed
Phase 2
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell Start of enrollment: 2011 Dec 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Management of post-autologous transplant relapse in patients with T-cell lymphomas.
Olivier Veilleux, Sally Arai, Matthew J Frank, Laura Johnston, Everett Meyer, Lori Muffly, Andrew R Rezvani, David B Miklos, Robert S Negrin, Francisco Socola, Robert ...> ;American Journal of Hematology. 2024 Apr 25
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol.
Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef, Donald E Tsai, Nancy J Bunin, Rolla F Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen Van Besien, David Loeb, Sunit...> ;Blood Advances. 2024 Apr 16
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.
Esther H Nie, Yi-Jiun Su, John H Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H Han, Jeffrey E Dunn, Lucas B Kipp, David B Mi...> ;Blood Advances. 2024 Mar 26
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD.
Rezvani, A. R., Cameron S Bader, Anna Pavlova, Robert Lowsky, Lori S Muffly, Parveen Shiraz, Sally Arai, Laura J Johnston, Andrew R Rezvani, Wen-Kai Weng, David B Mikl...> ;Blood Advances. 2024 Mar 12
Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas.
Eric Mou, Sebastian Fernandez-Pol, Shufeng Li, Kerri E Rieger, Roberto Novoa, Carlos J Suarez, Rebekah Wieland, Wen-Kai Weng, Youn H Kim, Michael S Khodadoust> ;American Journal of Hematology. 2024 May 1
8 citations
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.
Rezvani, A. R., Michael A Spinner, R A Sica, John S Tamaresis, Ying Lu, Cheryl Chang, Robert Lowsky, Matthew J Frank, Laura J Johnston, David B Miklos, Lori S Muffly, ...> ;Blood. 2023 Jun 1
3 citations
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era.
Rezvani, A. R., Emily C Liang, Juliana Craig, Stefan Torelli, Kristen Cunanan, Maria Iglesias, Sally Arai, Matthew J Frank, Laura Johnston, Robert Lowsky, Everett H Me...> ;Transplantation and Cellular Therapy. 2022 Aug 1
10 citations
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Rezvani, A. R., Andriyana K Bankova, Joseph Caveney, Bin Yao, Teresa L Ramos, Jan Bögeholz, Kartoosh Heydari, Nery Diaz, Marin L Jackson, Robert Lowsky, Janice Wes Bro...> ;Transplantation and Cellular Therapy. 2022 Apr 1
27 citations
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy
Andrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder, John S. Tamaresis, Robert S. Negrin, Laura Johnston, Sally Arai, Judith A...> ;Blood Advances. 2021 Nov 9
22 citations
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia.
, , , , , , , , , , , , , , , , , , , > ;Blood Advances. 2021 Aug 24
NUTRITIONAL DEFICIENCY CONTRIBUTING TO REFRACTORY ERYTHRODERMA IN HEMATOPOETIC CELL TRANSPLANT PATIENTS: DISTINCTIVE CLINICAL AND HISTOPATHOLOGICAL FINDINGS
Mårten C.G. Winge, Kerri E. Rieger, Jinah Kim, Wen-Kai Weng, Laura Johnston, David B. Miklos, Lisa C. Zaba, Silvina Pugliese, Roberto A. Novoa, Bernice Y. Kwong> ;Journal of the American Academy of Dermatology. 2021 Aug 25
232 citations
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird, Matthew J. Frank, Parveen Shiraz, Bita Sahaf, Juliana Craig, Maria Iglesias, Sher...> ;Nature Medicine. 2021 Jul 26
8 citations
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
Christopher Lemieux, Lori Muffly, David J. Iberri, Juliana Craig, Laura Johnston, Robert Lowsky, Parveen Shiraz, Andrew R. Rezvani, Matthew J. Frank, Wen-Kai Weng, Eve...> ;Bone Marrow Transplantation. 2021 Jun 23
49 citations
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma
Rezvani, A. R., John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren F. Younes, Michael G. Ozawa, Eric H. Yang, ...> ;Blood. 2021 Apr 29
6 citations
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafo...
Andrew Johnsrud, Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood, Judith A. Shizuru, Laura Johnston, Sally Arai, Wen-Kai Weng, Robert Lows...> ;Transplantation and Cellular Therapy. 2021 Jul 1
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation.
Y. Wu, Lawrie Skinner, Jonathan Lewis, Michael S. Khodadoust, Youn H. Kim, Bernice Y. Kwong, Wen-Kai Weng, Richard T. Hoppe, Quaovi H. Sodji, Noah Kastelowitz, Sebasti...> ;Cancer Investigation. 2021 Apr 25
3 citations
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Emily C. Liang, Lori Muffly, Parveen Shiraz, Judith A. Shizuru, Laura Johnston, Sally Arai, Matthew J. Frank, Wen-Kai Weng, Robert Lowsky, Andrew R. Rezvani, Everett M...> ;Transplantation and Cellular Therapy. 2021 Feb 25
17 citations
Pembrolizumab in mycosis fungoides with PD-L1 structural variants.
Sara Beygi, Sebastian Fernandez-Pol, George E. Duran, Erica B Wang, Henning Stehr, James L. Zehnder, Nirasha Ramchurren, Steven P. Fling, Martin A. Cheever, Wen-Kai We...> ;Blood Advances. 2021 Feb 9
15 citations
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.
Wen-Kai Weng, Sally Arai, Andrew R. Rezvani, Laura Johnston, Robert Lowsky, David B. Miklos, Judith A. Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wan...> ;Blood Advances. 2020 Sep 22
8 citations
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
Christopher Lemieux, Laura Johnston, Robert Lowsky, Lori Muffly, Juliana Craig, Parveen Shiraz, Andrew R. Rezvani, Matthew J. Frank, Wen-Kai Weng, Everett Meyer, Judit...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
20 citations
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
Matthew J. Frank, Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos, Ranjana H. Advani, Ash A. Alizadeh, Neel K. Gu...> ;The Journal of Experimental Medicine. 2020 Sep 7
6 citations
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma
Christopher Lemieux, Lori Muffly, Andrew R. Rezvani, Robert Lowsky, David J. Iberri, Juliana Craig, Matthew J. Frank, Laura Johnston, Michaela Liedtke, Robert S. Negri...> ;Bone Marrow Transplantation. 2021 Feb 1
2 citations
Pityriasis rubra pilaris‐like graft‐vs‐host disease following allogeneic stem cell transplant in two patients
Jennifer Y. Wang, Mika M. Tabata, Silvina Pugliese, Darci J. Phillips, Jinah Kim, Wen-Kai Weng, Bernice Y. Kwong> ;Clinical Case Reports. 2019 Nov 14
12 citations
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort
Michael A. Spinner, Vanessa E Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura Johnston, Everett Meyer, David B. Miklos, Lori Muffly, Robert S. Negrin, ...> ;Blood Advances. 2019 Aug 27
4 citations
Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs.
Jean-Pierre Obeid, Jonathan Lewis, Lawrie Skinner, Erica B Wang, Michael S. Khodadoust, Youn H. Kim, Wen-Kai Weng, Richard T. Hoppe, Susan M. Hiniker, Paulina M. Gutkin> ;Practical Radiation Oncology. 2019 Jul 1
Join now to see all

Abstracts/Posters

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...
Wen-Kai Weng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
Wen-Kai Weng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018